JACC: Advances - Nirmatrelvir-Ritonavir for Acute Covid-19 in Patients with Cardiovascular Disease and Post-Acute Sequelae of SARS-CoV-2-Infection
Release Date:
Commentary by Dr. Candice Silversides
JACC: Advances - Nirmatrelvir-Ritonavir for Acute Covid-19 in Patients with Cardiovascular Disease and Post-Acute Sequelae of SARS-CoV-2-Infection